Front Neurosci 18:1342944
These hormones play crucial roles in managing appetite and blood sugar control
Unlike supplements or diet pills, these treatments are FDA-approved and designed to work as part of a supervised medical weight loss program
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
REFLECTIONS ON GLP-1R AGONIST CLINICAL TRIALS The beneficial metabolic and microvascular actions of GLP-1 and GLP-1R agonist summarized in this article imply that GLP-1 is a physiological regulator of metabolic milieu and microvascular function and thus the use of GLP-1R agonist may confer benefits related to improved metabolism and circulatory function in patients with T2DM
This guide gives you the current 2026 state-by-state breakdown, explains what each authority level means in practical terms, and covers what NPs in reduced or restricted states need in place to operate compliantly including when a collaborating physician or medical director becomes legally required
